Products for managing diabetes, including blood glucose meters, test strips, lancets, continuous glucose monitoring sensors, insulin and delivery devices, oral and injectable medications, wound and foot care products, and accessories for blood glucose control and insulin storage.
Products for managing diabetes, including blood glucose meters, test strips, lancets, continuous glucose monitoring sensors, insulin and delivery devices, oral and injectable medications, wound and foot care products, and accessories for blood glucose control and insulin storage.
Medications in the Diabetes category are drugs used to help manage blood glucose levels in people with diabetes. This collection focuses mainly on oral and non-insulin treatments that act through different biological pathways to lower blood sugar, reduce peaks after meals, and influence longer-term measures of glycemic control. While some diabetes care involves injectable insulins or other injectable therapies, this category emphasizes oral agents and combination products that are commonly used in outpatient management.
These medicines are commonly used to address elevated fasting or post-meal blood glucose and to improve laboratory markers of glucose control over time. They can be used alone or together with other agents when a single medicine does not achieve the desired effect. Some products target quick rises in blood sugar after eating, while others act more steadily over the day; clinicians select treatments based on how a particular medicine affects glucose patterns, tolerability, and any coexisting health concerns.
The category contains several major drug classes and representative products. Biguanides, typified by metformin (examples include Glucophage, Glucophage SR/XR, Glycomet), are among the most commonly used oral agents. Sulfonylureas and related secretagogues such as glimepiride (Amaryl), glipizide (Glucotrol/Glucotrol XL), and older preparations like glyburide (Micronase) increase insulin release. Thiazolidinediones such as pioglitazone (Actos) affect insulin sensitivity, and combination pills that pair agents—like pioglitazone plus metformin (Actoplus Met), metformin plus a sulfonylurea (Glucovance), or metformin with a DPP‑4 inhibitor (Jentadueto XR)—offer convenience. Other types include meglitinides (repaglinide/Prandin), alpha‑glucosidase inhibitors (acarbose/Precose), and newer incretin‑based oral options such as oral semaglutide (Rybelsus).
Safety profiles vary across these medicines and are an important part of choosing a treatment. Gastrointestinal symptoms are commonly reported with metformin and some incretin‑based drugs, while sulfonylureas and meglitinides are associated with a risk of low blood glucose. Certain agents have been linked with weight gain or fluid retention, and some require attention to kidney or liver function because of how they are processed by the body. Drug–drug interactions and individual medical conditions can influence tolerability and suitability for specific patients.
When evaluating options within this category, people often consider how a medication is taken, how frequently dosing is required, and whether extended‑release or combination formulations are available to simplify regimens. Other commonly weighed factors include the expected effect on fasting versus postprandial glucose, the potential for side effects such as gastrointestinal upset or hypoglycemia, effects on body weight, and whether a product is available in generic form. Practical considerations such as pill size, once‑daily versus multiple‑daily dosing, and the need for routine laboratory monitoring also influence choice.
Products are offered in a range of formulations—immediate‑release, sustained‑release, fixed‑dose combinations and newer oral agents—and naming and availability can differ between regions. Healthcare professionals generally match a medication’s characteristics to a person’s overall health profile, coexisting conditions and treatment goals. Product labels and regulatory approvals provide specific information on indications and safety for each individual medicine.
—